NYSE:MT • US03938L2034
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARCELORMITTAL-NY REGISTERED (MT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-09 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2026-02-11 | Jefferies | Upgrade | Hold -> Buy |
| 2026-02-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-17 | UBS | Downgrade | Buy -> Neutral |
| 2025-11-07 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-10-23 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-14 | Wells Fargo | Initiate | Equal-Weight |
| 2025-07-16 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-04-10 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-03-26 | Jefferies | Downgrade | Buy -> Hold |
| 2024-10-11 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-08-28 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2024-08-19 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2024-08-02 | Deutsche Bank | Maintains | Hold -> Hold |
| 2024-05-09 | Goldman Sachs | Initiate | Neutral |
| 2024-04-16 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2023-12-12 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2023-10-18 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-04-03 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2023-03-29 | UBS | Upgrade | Sell -> Buy |
| 2023-03-23 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-02-10 | Deutsche Bank | Maintains | Buy |
| 2022-12-14 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-10-06 | UBS | Downgrade | Buy -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 68.275B -14.49% | 62.441B -8.54% | 61.352B -1.74% | 69.161B 12.73% | 72.517B 4.85% | 72.417B -0.14% | 76.331B 5.40% | 76.423B 0.12% | |
| EBITDA YoY % growth | 7.67B -44.73% | 6.274B -18.20% | 5.452B -13.10% | 8.874B 62.77% | 10.266B 15.69% | 10.559B 2.85% | 11.771B 11.48% | 9.881B -16.06% | |
| EBIT YoY % growth | 4.883B -56.78% | 3.642B -25.41% | 2.507B -31.16% | 5.352B 113.48% | 6.468B 20.85% | 6.499B 0.48% | 7.408B 13.99% | 7.379B -0.39% | |
| Operating Margin | 7.15% | 5.83% | 4.09% | 7.74% | 8.92% | 8.97% | 9.71% | 9.66% | |
| EPS YoY % growth | 5.75 -47.68% | 2.94 -48.87% | 3.84 30.61% | 5.37 39.91% | 6.70 24.62% | 6.83 2.07% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.94 -10.01% | 1.42 7.71% | 1.31 111.87% | 1.43 66.07% | 1.64 74.99% | 1.66 17.00% | 1.58 20.44% | 1.60 12.14% |
| Revenue Q2Q % growth | 16.707B 12.90% | 17.428B 9.43% | 17.103B 9.24% | 17.607B 17.61% | 18.467B 10.53% | 18.555B 6.47% | 18.163B 6.20% | 18.418B 4.61% |
| EBITDA Q2Q % growth | 1.898B 28.16% | 2.252B -10.31% | 2.025B -30.75% | 2.314B -26.89% | 2.384B 25.61% | 2.404B 6.75% | 2.316B 14.37% | 2.327B 0.56% |
| EBIT Q2Q % growth | 1.057B 28.12% | 1.391B 44.29% | 1.364B 112.79% | 1.601B 627.73% | 1.63B 54.21% | 1.65B 18.62% | 1.562B 14.52% | 1.573B -1.75% |
All data in USD
26 analysts have analysed MT and the average price target is 60.03 USD. This implies a price increase of 23.8% is expected in the next year compared to the current price of 48.49.
ARCELORMITTAL-NY REGISTERED (MT) will report earnings on 2026-04-30.
The consensus EPS estimate for the next earnings of ARCELORMITTAL-NY REGISTERED (MT) is 0.94 USD and the consensus revenue estimate is 16.71B USD.
The consensus rating for ARCELORMITTAL-NY REGISTERED (MT) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.